Tolerance Bio Inc.

About Tolerance Bio Inc.

Tolerance Bio aims to increase health span by preserving, restoring, and manipulating the function of the thymus, which is the master regulator of immune tolerance.

Products & Services

Thymus-Based Therapies:Therapies focused on restoring, preserving, and manipulating thymus function to control immune tolerance and treat immune-mediated diseases.

Specialties

Thymus Function Manipulation Immune Tolerance Thymus-Based Therapies Immune-Mediated Diseases

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 17200000 MR: - FA: $17.2 million FAN: 17200000	D: 2024-10-15 FD: 2024-10-15	6 investors

Seed Latest

2024-10-15

$17.2M

6 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

H

Holger Russ

Scientific Co-founder

LinkedIn (Pro only)

M

Megan Sykes

Michael J. Friedlander Professor of Medicine and Professor of Microbiology & Immunology and Surgical Sciences (in Surgery), Columbia University

C

Camillo Ricordi

Professor of Surgery, Distinguished Professor of Medicine, Professor of Biomedical Engineering, and Microbiology and Immunology at the University of Miami; Chief of the Division of Cellular Transplantation; Director of the Cell Transplant Center; Director Emeritus of the Diabetes Research Institute; Medical Director of the NIH-funded cGMP Advanced Human Cell and Biologic Product Manufacturing Facility

J

Jerome Ritz

Professor of Medicine

M

Manasi Jaiman

Chief Medical Officer

R

Roland Kolbeck

Chief Scientific Officer

View 12 more team members with Pro

Unlock Full Team Directory

Recent News